Published in Hepatitis Weekly, March 12th, 2001
"Standardization of nucleic acid amplification technology (NAT) assays is necessary before the introduction of such assays for routine screening of blood and blood products for viral contaminants such as HBV, HCV, and HIV-1," said J. Saldanha and colleagues at England's National Institute for Biological Standards and Controls.
While reference reagents for many such viruses are available, their nucleic acid content is measured in a multitude of different and often...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2001-03-12)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.